Teh Seng Pharmaceutical Mfg Co (ROCO:7860) ROIC %: 9.78% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7860 Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
23 GF Score
Price NT$81.50
! 7 Warning Signs
View Full Analysis

What is Teh Seng Pharmaceutical Mfg Co ROIC %?

Teh Seng Pharmaceutical Mfg Co ROCO:7860 +4.35% 23 ROIC % is 9.78% as of Dec. 2025. GuruFocus rates ROCO:7860 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Teh Seng Pharmaceutical Mfg Co's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2025 was 9.78%.

As of today (2026-07-20), Teh Seng Pharmaceutical Mfg Co's WACC % is 9.98%. Teh Seng Pharmaceutical Mfg Co's ROIC % is 11.45% (calculated using TTM income statement data). Teh Seng Pharmaceutical Mfg Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Teh Seng Pharmaceutical Mfg Co  (ROCO:7860) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Teh Seng Pharmaceutical Mfg Co's WACC % is 9.98%. Teh Seng Pharmaceutical Mfg Co's ROIC % is 11.45% (calculated using TTM income statement data). Teh Seng Pharmaceutical Mfg Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Teh Seng Pharmaceutical Mfg Co ROIC % Related Terms


Teh Seng Pharmaceutical Mfg Co ROIC % Historical Data

* Premium members only.

The historical data trend for Teh Seng Pharmaceutical Mfg Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teh Seng Pharmaceutical Mfg Co ROIC % Chart

Teh Seng Pharmaceutical Mfg Co Annual Data
Trend Dec23 Dec24 Dec25
ROIC %
9.31 15.13 11.61

Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
ROIC % 0.00 9.83 20.90 12.13 9.78

ROCO:7860 vs ZTS, UTHR: ROIC % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teh Seng Pharmaceutical Mfg Co ROIC % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's ROIC % falls into.


ROCO:7860
23GF Score
Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teh Seng Pharmaceutical Mfg Co ROIC % Calculation

Teh Seng Pharmaceutical Mfg Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=140.722 * ( 1 - 23.46% )/( (957.328 + 898.775)/ 2 )
=107.7086188/928.0515
=11.61 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1474.531 - 125.163 - ( 450.062 - max(0, 387.889 - 779.929+450.062))
=957.328

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1403.371 - 97.444 - ( 407.152 - max(0, 282.195 - 698.219+407.152))
=898.775

Teh Seng Pharmaceutical Mfg Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2025 is calculated as:

ROIC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=113.09 * ( 1 - 19.41% )/( (965.279 + 898.775)/ 2 )
=91.139231/932.027
=9.78 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1465.184 - 166.258 - ( 435.69 - max(0, 412.741 - 746.388+435.69))
=965.279

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1403.371 - 97.444 - ( 407.152 - max(0, 282.195 - 698.219+407.152))
=898.775

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 9.78% mean?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a ROIC % of 9.78% as of Dec. 2025. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors.
Is Teh Seng Pharmaceutical Mfg Co's ROIC % too high?
Teh Seng Pharmaceutical Mfg Co's current ROIC % is 9.78%. The Drug Manufacturers industry median ROIC % is 4.46. Teh Seng Pharmaceutical Mfg Co's value of 9.78% is 119.3% above this industry median. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's ROIC % compare to ZTS and UTHR?
Teh Seng Pharmaceutical Mfg Co's ROIC % of 9.78% can be compared against companies in the Drug Manufacturers industry. The industry median ROIC % is 4.46. Teh Seng Pharmaceutical Mfg Co's value of 9.78% is 119.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Drug Manufacturers company?
The median ROIC % among Drug Manufacturers companies is 4.46, based on 988 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teh Seng Pharmaceutical Mfg Co's current ROIC % of 9.78% is 119.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. For the Drug Manufacturers industry, the median ROIC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current ROIC % is 9.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current ROIC % of 9.78%. The current ROIC % is 9.78% and 119.3% above the Drug Manufacturers industry median of 4.46. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current ROIC % is 9.78% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Teh Seng Pharmaceutical Mfg Co Business Description

Address No.42,Huan Gong Road, Yong Kang District, Tainan, TWN, 710001
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
23GF Score

Get the complete analysis for ROCO:7860

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$81.50
Price